JARGIN, S. V. Management of Type 2 Diabetes Mellitus with Overweight: Focus on SGLT-2 Inhibitors and GLP-1 Receptor Agonists. European Journal of Therapeutics, [S. l.], v. 25, n. 2, p. 93–96, 2023. DOI: 10.5152/EurJTher.2019.18067. Disponível em: https://eurjther.com/index.php/home/article/view/397. Acesso em: 3 jul. 2024.